Comparison of Caudal and Quadratus Lumborum Blocks With Pain Monitoring in Children
Comparison of the Analgesic Efficacy of Caudal and Quadratus Lumborum Blocks With Pain Monitoring in Lower Abdominal Surgery in Children
1 other identifier
observational
68
1 country
1
Brief Summary
Study Type: Prospective, Randomized, Observational Clinical Study Primary Purpose: The primary objective of this study is to compare the analgesic efficacy of caudal block (CB) and quadratus lumborum block (QLB) in children undergoing lower abdominal surgery using objective pain monitoring methods. Key Questions Addressed: Does the quadratus lumborum block provide superior intraoperative and postoperative analgesia compared to the caudal block, as measured by the Pain Monitor (PAM) and the FLACC scale? Is the PAM monitor a reliable tool for objectively assessing nociception and pain in children who are unable to verbally express pain? Which regional anesthesia technique more effectively delays the time to first postoperative analgesic requirement and reduces total analgesic consumption? Which method is associated with higher parental satisfaction and fewer postoperative side effects, such as postoperative nausea and vomiting? Comparison Groups: Children receiving ultrasound-guided quadratus lumborum block will be compared with those receiving caudal block. Intervention Group: Bilateral quadratus lumborum block with 0.5 mL/kg of 0.25% bupivacaine. Active Comparator Group: Caudal block with 1 mL/kg of 0.125% bupivacaine. Participant Population: A total of 68 children, aged 2 months to 6 years, with ASA physical status I-II, scheduled for elective lower abdominal surgeries (e.g., inguinal hernia repair, orchiopexy, hydrocele). What Participants Will Do: Participants will receive the assigned regional block as part of standard anesthetic care. Observational data will be collected as follows: Intraoperative: Continuous nociception monitoring using the PAM device at predefined time points (during laryngeal mask airway insertion, block performance, surgical incision, 20 minutes after block performance, and extubation). Postoperative: Pain assessment using the FLACC scale at 1, 2, and 4 hours in the post-anesthesia care unit. Rescue analgesia (intravenous paracetamol) will be administered if the FLACC score is ≥4. Time to first analgesic administration and total analgesic consumption will be recorded. Additional outcomes include postoperative nausea and vomiting (PONV) scores, Steward recovery scores, and parental satisfaction scores assessed using the Pediatric Parental Satisfaction Scale (PPPS). Primary Outcome: Intraoperative PAM index scores. Secondary Outcomes: Postoperative FLACC scores, time to first analgesic requirement, total postoperative analgesic consumption, incidence and severity of PONV, Steward recovery scores, and parental satisfaction (PPPS) scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2025
CompletedStudy Start
First participant enrolled
February 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2026
CompletedFirst Posted
Study publicly available on registry
February 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedFebruary 10, 2026
February 1, 2026
Same day
September 18, 2025
February 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative Pain Index Scores Measured by MEDSTORM Pain Monitor (PAM)
The intraoperative analgesic efficacy of Caudal Block and Quadratus Lumborum (QL) Block will be assessed using the MEDSTORM Pain Monitor (PAM). The PAM provides a Pain Index score ranging from 0 to 10, reflecting the patient's nociceptive state and the need for analgesic intervention. Lower scores indicate better analgesic efficacy. Pain Index scores will be recorded at predefined perioperative time points. It is hypothesized that the QL block will result in lower intraoperative Pain Index scores compared to the caudal block. Pain Index interpretation: 0-1: No additional analgesia required 2-3: Additional analgesia may be required 4-5: Additional analgesia is likely required 6-7: Additional analgesia is probably needed 8-10: Additional analgesia is required Perioperative period, at the following predefined time points: At airway instrumentation During regional block performance At skin incision 20 minutes after block performance At emergence from anesthesia
Perioperative period, at the following predefined time points: At airway instrumentation (laryngeal mask airway insertion) During regional block performance At skin incision 20 minutes after block performance At emergence from anesthesia (extubation)
Secondary Outcomes (7)
Postoperative Pain Intensity Measured by FLACC Scale
Postoperative period, assessed at: 1 hour after surgery 2 hours after surgery 4 hours after surgery
Time to First Postoperative Analgesic Requirement
Postoperative period, up to 4 hours after surgery
Number of Participants Requiring Postoperative Rescue Analgesia
Postoperative period, assessed at: 1 hour 2 hours 4 hours after surgery
Total Postoperative Paracetamol Dose Administered
Time Frame Postoperative period, up to 4 hours after surgery
Adverse Effects, Postoperative Nausea and Vomiting (PONV) Severity Score
Postoperative period, assessed at: 1 hour 2 hours 4 hours after surgery
- +2 more secondary outcomes
Study Arms (2)
QUADRATUS LUMBORUM BLOCK GROUP
Intraoperatively, under ultrasound guidance, bilateral QL block with 0.5 ml/kg of 0.25% bupivacaine (maximum volume 20 ml) will be performed.
CAUDAL BLOCK GROUP
Under ultrasound guidance, a caudal block with 1 ml/kg of 0.125% bupivacaine (maximum volume 20 ml) will be performed.
Eligibility Criteria
Children aged 2 months to 6 years with ASA I-II status undergoing lower abdominal surgeries (e.g., inguinal hernia, orchiopexy, hydrocele) performed by the pediatric surgery unit at Etlik City Hospital will be included.
You may qualify if:
- Pediatric patients between 2 months and 6 years of age
- Pediatric patients undergoing lower abdominal surgery
- Family consent must be obtained
- No contraindications to block (infection at the block site), coagulopathy (INR \<1.4, platelets \>100,000), local anesthetic allergy)
- ASA I-II patients
You may not qualify if:
- Severe systemic disease (ASA ≥III)
- Infection at the block site
- Coagulopathy (INR \>1.4, platelets \<100,000)
- Local anesthetic allergy
- Parental refusal
- Children aged \<2 months or \>6 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Etlik City Hospital
Ankara, YENIMAHALLE, 06170, Turkey (Türkiye)
Related Publications (3)
Aksu C, Sen MC, Akay MA, Baydemir C, Gurkan Y. Erector Spinae Plane Block vs Quadratus Lumborum Block for pediatric lower abdominal surgery: A double blinded, prospective, and randomized trial. J Clin Anesth. 2019 Nov;57:24-28. doi: 10.1016/j.jclinane.2019.03.006. Epub 2019 Mar 6.
PMID: 30851499BACKGROUNDLedowski T. Objective monitoring of nociception: a review of current commercial solutions. Br J Anaesth. 2019 Aug;123(2):e312-e321. doi: 10.1016/j.bja.2019.03.024. Epub 2019 Apr 30.
PMID: 31047645BACKGROUNDZhu Y, Wu J, Qu S, Jiang P, Bohara C, Li Y. The analgesic effects of quadratus lumborum block versus caudal block for pediatric patients undergoing abdominal surgery: a systematic review and meta-analysis. Front Pediatr. 2025 Feb 6;13:1492876. doi: 10.3389/fped.2025.1492876. eCollection 2025.
PMID: 39981211BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
ASLI DONMEZ, Professor
Etlik City Hospital Health Science University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sub-Investigator
Study Record Dates
First Submitted
September 18, 2025
First Posted
February 10, 2026
Study Start
February 2, 2026
Primary Completion
February 2, 2026
Study Completion
April 30, 2026
Last Updated
February 10, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Because it was not specified in the ethics committee.